Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NFIA |
| Upstream (Parents) |
|---|
| (<<) TFAP2B → NFIA |
| (<<) FOXA1 → NFIA |
| (<<) EN1 → NFIA |
| (<<) ZIC1 → NFIA |
| (<<) ANKRD30A → NFIA |
| (<<) SPDEF → NFIA |
| (<<) NFIX → NFIA |
| (<<) TAF4B → NFIA |
| (<<) GLIS3 → NFIA |
| (<<) XBP1 → NFIA |
| (<<) TFDP1 → NFIA |
| (<<) TSC22D3 → NFIA |
| (<<) SOX13 → NFIA |
| (<<) EPAS1 → NFIA |
| (<<) ALX1 → NFIA |
| (<<) GATA2 → NFIA |
| (<<) GTF2H4 → NFIA |
| Downstream (Children) |
|---|
| NFIA → CDKN2A (>>) |
| NFIA → EHF (>>) |
| NFIA → FOXD1 (>>) |
| NFIA → PAX6 (>>) |
| NFIA → ESRRG (>>) |
| NFIA → FOXC2 (>>) |
| NFIA → NFIB (>>) |
| NFIA → ARNTL2 (>>) |
| NFIA → NR4A2 (>>) |
| NFIA → SCAND3 (>>) |
| NFIA → RORC (>>) |
| NFIA → ZNF91 (>>) |
| NFIA → LHX2 (>>) |
| NFIA → THRB (>>) |
| NFIA → PCGF2 (>>) |
| NFIA → MTA1 (>>) |
| NFIA → POU4F1 (>>) |
| NFIA → ATF7 (>>) |
| NFIA → SCML2 (>>) |
